HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

AIRS

AirSculpt Technologies, Inc. (NASDAQ)

Healthcare — Medical Care Facilities

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.

None 1 analysts
$4.50
$-0.09 (-0.44%)
Target: $4.50 (0.0%)
Sign in to add AIRS to a watchlist or set price alerts.

Price History

Fundamentals

Market Cap$310.40M
P/E Ratio (TTM)-
Forward P/E-220.00
EPS (TTM)$-0.17
Dividend Yield-
Profit Margin-7.39%
Revenue Growth-
ROE-
Debt/Equity-
Recommendation None
Analyst Target$4.50
Analysts1
Indexes NASDAQ

Technical Indicators

RSI (14)31.4
Beta2.34
SMA 20-
SMA 40-
52-Week High-
52-Week Low-
50-Day Avg-
200-Day Avg-
Avg Volume-
Volume-

Performance Analysis

BEARISH

AIRS is flashing more cautionary signals — investors should monitor closely.

~ RSI at 31.4 is in neutral territory.
- Operating at a loss with -7.4% margin.
~ Wall Street consensus is "none" from 1 analysts.
- Average analyst target of $4.50 implies 0.0% downside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 01, 2026 11:46 UTC

Back to Screener Export Report